New drug BBT002 aims to ease sinus and asthma symptoms
Symptom relief
Not yet recruiting
This early-stage study tests a new drug called BBT002 in healthy volunteers and people with chronic sinusitis, nasal polyps, and asthma. The main goal is to check the drug's safety and how the body processes it. Researchers will also look for signs that the drug helps control sym…
Phase: PHASE1, PHASE2 • Sponsor: Bambusa Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC